Cardinal Capital Management Inc (North Carolina)’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.41M | Buy |
11,876
+177
| +2% | +$50.9K | 0.5% | 66 |
|
|
2025
Q1 | $3.61M | Buy |
11,699
+631
| +6% | +$195K | 0.56% | 63 |
|
|
2024
Q4 | $3.91M | Buy |
11,068
+208
| +2% | +$73.4K | 0.61% | 58 |
|
|
2024
Q3 | $3.89M | Buy |
10,860
+621
| +6% | +$223K | 0.61% | 57 |
|
|
2024
Q2 | $3.26M | Buy |
10,239
+284
| +3% | +$90.5K | 0.55% | 59 |
|
|
2024
Q1 | $2.29M | Buy |
9,955
+1,675
| +20% | +$385K | 0.37% | 83 |
|
|
2023
Q4 | $1.82M | Buy |
8,280
+40
| +0.5% | +$8.8K | 0.34% | 85 |
|
|
2023
Q3 | $1.86M | Buy |
8,240
+146
| +2% | +$33K | 0.38% | 79 |
|
|
2023
Q2 | $1.79M | Buy |
8,094
+102
| +1% | +$22.5K | 0.36% | 82 |
|
|
2023
Q1 | $1.79M | Buy |
7,992
+4
| +0.1% | +$896 | 0.37% | 82 |
|
|
2022
Q4 | $2.22M | Buy |
7,988
+85
| +1% | +$23.6K | 0.47% | 69 |
|
|
2022
Q3 | $1.66M | Buy |
7,903
+109
| +1% | +$22.8K | 0.39% | 77 |
|
|
2022
Q2 | $1.84M | Buy |
7,794
+81
| +1% | +$19.1K | 0.42% | 71 |
|
|
2022
Q1 | $1.38M | Buy |
7,713
+732
| +10% | +$131K | 0.28% | 92 |
|
|
2021
Q4 | $1.51M | Buy |
6,981
+65
| +0.9% | +$14K | 0.3% | 88 |
|
|
2021
Q3 | $1.28M | Buy |
6,916
+115
| +2% | +$21.2K | 0.28% | 94 |
|
|
2021
Q2 | $1.22M | Buy |
6,801
+95
| +1% | +$17K | 0.26% | 102 |
|
|
2021
Q1 | $1.12M | Buy |
6,706
+110
| +2% | +$18.4K | 0.25% | 102 |
|
|
2020
Q4 | $1M | Buy |
6,596
+308
| +5% | +$46.7K | 0.24% | 102 |
|
|
2020
Q3 | $635K | Buy |
6,288
+364
| +6% | +$36.8K | 0.17% | 110 |
|
|
2020
Q2 | $716K | Sell |
5,924
-840
| -12% | -$102K | 0.21% | 105 |
|
|
2020
Q1 | $641K | Buy |
6,764
+842
| +14% | +$79.8K | 0.21% | 108 |
|
|
2019
Q4 | $522K | Buy |
+5,922
| New | +$522K | 0.14% | 123 |
|